Publication Type : Patents
Thematic Areas : Nanosciences and Molecular Medicine
Publisher : U.S. Patent Australian Provisional Patent Application
Source : Number Australian Provisional Patent Application no: 2016903294 (Patent Filed) (2017)
Campus : Kochi
School : Center for Nanosciences, School of Pharmacy
Center : Amrita Center for Nanosciences and Molecular Medicine Move, Nanosciences
Department : Nanosciences and Molecular Medicine, Pharmaceutical Chemistry & Analysis, Nanosciences
Year : 2017
Abstract : (EN) The present invention relates to compositions and methods for the treatment or prevention of autoimmune diseases such as demyelination disorders. The invention includes a composition comprising a peptide antigen comprising at least one beta (β) amino acid coupled to a carrier nano or microparticle of silica. In one embodiment the demyelination disorder is multiple sclerosis. (FR) La présente invention concerne des compositions et des méthodes pour le traitement ou la prévention de maladies autoimmunes telles que des affections démyélinisantes. L'invention comprend une composition comprenant un antigène peptidique comprenant au moins un acide aminé beta (β) couplé à un support constitué d'une nanopartcule ou microparticule de silice. Dans un mode de réalisation, l'affection démyélinisante est la sclérose en plaques.
Cite this Research Publication : Bernard, C. C. A., Krishnakumar N. Menon, Sadanandan, P., Payne, N. L., and Shantikumar V Nair, “Compositions and Methods for Autoimmune Disease Treatment Inventors”, U.S. Patent Australian Provisional Patent Application no: 2016903294 (Patent Filed)2017.